Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001326110-21-000005)

Filing Details

Accession Number:: 0001326110-21-000005
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-10-08 20:31:00
Reporting Period:: 2021-10-08

Accepted Time:: 2021-10-08 20:31:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326110	Immunitybio Inc.	IBRX	Biological Products, (No Disgnostic Substances) (2836)	431979754

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1830328	Richard Adcock	C/O Immunitybio, Inc. 3530 John Hopkins Court San Diego CA 92121	Ceo & President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-10-08	7	$9.00	7	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2021-10-08	1,923	$8.81	1,930	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	86,176	Direct

Footnotes

Shares held by girlfriend living in the same household as the Reporting Person. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.